Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Carcinoma, Oat Cell

glucose, (beta-d)-isomer has been researched along with Carcinoma, Oat Cell in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kanzawa, F; Kubota, N; Nishio, K; Saijo, N1
Arioka, H; Bojanowski, K; Fukuda, M; Ishida, T; Kanzawa, F; Nishio, K; Ogasawara, H; Oka, M; Saijo, N1

Other Studies

2 other study(ies) available for glucose, (beta-d)-isomer and Carcinoma, Oat Cell

ArticleYear
Antitumor activities of a new indolocarbazole substance, NB-506, and establishment of NB-506-resistant cell lines, SBC-3/NB.
    Cancer research, 1995, Jul-01, Volume: 55, Issue:13

    Topics: Antineoplastic Agents; Camptothecin; Carbazoles; Carcinoma, Small Cell; Cell Nucleus; Drug Resistance; Glucosides; Humans; In Vitro Techniques; Irinotecan; Topoisomerase I Inhibitors; Tumor Cells, Cultured

1995
Synergism between cisplatin and topoisomerase I inhibitors, NB-506 and SN-38, in human small cell lung cancer cells.
    Cancer research, 1996, Feb-15, Volume: 56, Issue:4

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carbazoles; Carcinoma, Small Cell; Cell Division; Cell Nucleus; Cell Survival; Cisplatin; DNA Repair; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Glucosides; Humans; Irinotecan; Lung Neoplasms; Topoisomerase I Inhibitors; Tumor Cells, Cultured

1996